CASC11 and hepatocellular carcinoma: The present study showed that high expression level of CASC11 was closely correlated with the poor survival of HCC patients, and overexpression of CASC11 may inhibit HCC by reducing the proliferation of HCC cells through the down-regulation of miR-188-5p, which is a tumor suppressor in HCC [13].